The tourism industry in Assam is on a rebound after a dull patch during the COVID-19 pandemic. The number of tourists increased at Assam State Zoo Cum Botanical Garden after the state government exempt some relaxations under COVID-19 guidelines. With this relaxation, visitors' footfall has increased and tourism industry is recovering from COVID impact.
Another detailed study by the American Association for the Advancement of Science asserts that the SARS-CoV-2 virus not only targets to enter the human cells but begin to replicate and spread as well. The findings also highlight that the possibilities could potentially serve as targets for new therapies for patients with COVID-19, although validation in cells and animal models is needed. Scientists know that SARS-CoV-2 binds the ACE2 receptor on the surface of human cells, after which it enters the cell through a process known as endocytosis. Research has suggested that the virus may hijack or interfere with other processes such as cellular housekeeping (autophagy) by targeting other receptors called integrins. However, not much is known about exactly how the virus takes advantage of integrins on the biochemical level.
CNN’s Anderson Cooper speaks to NYU marketing professor Scott Galloway about his new book, “Post Corona: From Crisis to Opportunity,” and about how the Covid-19 pandemic has transformed the business world. Watch Anderson Cooper Full Circle Monday, Tuesday and Friday this week at 6p E.T.
White House national economic council director Brian Deese told reporters Friday, “Now’s not the time to wait and see, now’s the time to act,” ahead of President Biden’s signing of two executive orders to speed the delivery of coronavirus stimulus checks and food aid. This report produced by Emma Jehle.
India is supplying COVID-19 vaccines being manufactured in the country to neighbouring countries including Bhutan, Maldives, Nepal, Myanmar and Bangladesh but has not received any request from Pakistan. Addressing the weekly media briefing, Ministry of External Affairs Spokesperson Anurag Srivastava said there is an interest in accessing vaccines from India, which is the global hub of vaccine production. He said Prime Minister Narendra Modi had stated that India's vaccine production and delivery capacity will be used for the benefit of all humanity to fight the COVID-19 pandemic. "I am not aware of any request for the supply of Indian-made vaccines to Pakistan on a G2G basis or commercial basis," Srivastava said answering a query. Watch the full video for more details.
Credit: HT Digital Content Duration: 03:02Published
The Ministry of External Affairs (MEA) Spokesperson Anurag Srivastava on January 22 said that he is not aware of any request either G2G or commercial basis by Pakistan for Indian made vaccines. "I am not aware of any request for the supply for Indian made vaccines by Pakistan on a Government to Government or commercial basis," said MEA Spokesperson.